The design and development of therapeutic agents for neuromuscular diseases.
D002626:Chemistry, Pharmaceutical; D004341:Drug Evaluation; D004345:Drug Industry; D006801:Humans; D009136:Muscular Dystrophies / Q000188:drug therapy / Q000209:etiology; D009316:National Institutes of Health (U.S.); D009468:Neuromuscular Diseases / Q000188:drug therapy*; D009965:Orphan Drug Production; D012106:Research; D014481:United States